Our Science
Peer-reviewed perspectives and white papers examining unmet needs, treatment continuity, and the case for individualised dosing in clinical practice.
Hormonal influences on stimulant treatment in girls and women with ADHD
Clinical relevance, unmet needs, and implications for personalised care – a review of the current literature
WHITE PAPER - Hormonal influences on stimulant treatment in girls and women with ADHD (pdf, 205KB)
Individualised dose optimisation in ADHD.
Clinical rationale, current practice gaps, and implications for treatment continuity – a review of the current literature
WHITE PAPER - Individualised dose optimisation in ADHD (pdf, 666KB)
Dose performance of the OnDosis Minitablet Dosage Manager
Individualised dosing is increasingly needed in areas like psychiatry, neurology, paediatrics, and rare diseases, where patient variability and narrow therapeutic windows demand precise dose control. Conventional solid forms come in limited fixed strengths, making it hard for clinicians to fine-tune or titrate doses in small increments.
WHITE PAPER - OnDosis Minitablet Dosage Manager (pdf, 285KB)
Usability evaluation of an innovative device technology for individualized dosing of oral solid medicines
The Dosage Manager is a handheld device that delivers precise, flexible pellet doses. It targets fields like psychiatry, neurology, paediatrics, rare diseases, and oncology.
Ondosis White Paper - Usability (pdf, 990KB)
Achieving individualised dosing with pellet formulations combined with an innovative device technology
Conventional oral solids come in few fixed strengths that prevent fine dose adjustment, which is problematic in paediatric treatment where efficacy must be balanced against side-effects and where swallowing large tablets is hard. This study evaluated the dosing accuracy and precision of an innovative device designed for individualised, flexible dosing of pellet-formulated medicines.
Poster EuPFI (pdf, 977KB)